[ad_1]
While the big media buzz around Novo Nordisk lately is around obesity drugs, the Denmark-based pharma is also and still the largest diabetes treatment company in the world.
Today, the day after World Diabetes Day, we’re featuring a conversation with Katrine DiBona, Novo Nordisk’s VP of global public affairs and sustainability.
DiBona oversees Novo Nordisk sustainability efforts across a range of corporate, environmental and social initiatives. From programs around net zero carbon goals and recycling plastic from insulin pens to social movements that coordinate community and national groups such as Cities Changing Diabetes and Changing Diabetes in Children, DiBona and her team work across the growing issues of diabetes — and Novo’s corporate responsibility to address them.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,000+ biopharma pros reading Endpoints daily — and it’s free.
[ad_2]
Source link
